UTILISATION DE L'EXPRESSION MIR-199A-5P, CIBLES ET/OU INHIBITEURS DE CELLE-CI POUR LE DIAGNOSTIC, LE PRONOSTIC ET LE TRAITEMENT DE TROUBLES FIBROPROLIFERATEURS
The present invention relates to the use of the miRNA expression profile, particularly of miR-199a-5p, and the target genes regulated thereby for the diagnosis, prognosis and use of miR-199a-5p inhibitors for treating fibroproliferative disorders.